Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janelle Perkins

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Hematology|January 20, 2011
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complicationsJoseph Pidala, Jaime Roman-Diaz, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantationJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allograftingMohamed A Kharfan-Dabaja, Claudio Anasetti, Hugo F Fernandez, et al.
Haematologica|June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantationJoseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromeMohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Hematology|January 20, 2011
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complicationsJoseph Pidala, Jaime Roman-Diaz, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantationJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allograftingMohamed A Kharfan-Dabaja, Claudio Anasetti, Hugo F Fernandez, et al.
Haematologica|June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantationJoseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromeMohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
Pageof 3